« Return to News | Technology Solutions

CoE launches eTACT to authenticate drugs with smartphones

Monday, February 13, 2012 03:11 PM

The Council of Europe (CoE) and its European Directorate for the Quality of Medicines & HealthCare (EDQM) have launched eTACT, an IT-based traceability service that will allow patients to check the authenticity of their medicines using smartphones or the internet.

Part of the CoE’s global strategy to counter fake drugs, eTACT is a publicly governed service which covers all medicines in the legal supply chain and will trace drugs’ origins through existing national systems. The technology will be open to the 36 member states of the European Pharmacopoeia Commission and beyond.

EDQM organized a workshop in late January for stakeholders, regulatory authorities and patient organizations to use and discuss the technology. The International Alliance of Patients' Organizations specifically welcomed the EDQM’s initiative to open the service to patients and underlined the importance of value to patients versus costs.

Consultations, technical workshops and a series of webinars are to be organized in the coming months to help users understand the project and to gather ideas to create an optimum traceability environment for medicines.

Share:          
CWWeekly

May 21

Parexel consultant testifies on FDA biosimilars guidance

Global Telecom Testing checks ex-U.S. toll-free phone lines for multinational clinical trials

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

May

Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…

Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…

Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2012 CenterWatch.